Melissa R. Gertler AssociateSheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comOrganization ProfileFull ProfileConnectEmail424-288-5314 Professional Biography Melissa Gertler is an associate in the Corporate Practice Group in the firm's Century City office. More Legal and Business Bylines From Melissa R. Gertler Elijah E. Cummins Lower Drug Costs Now Act: The Long and Winding Road to Drug Pricing Reform - (Posted On Wednesday, September 22, 2021) The Infrastructure Investment and Jobs Act: Potential Impact on Healthcare Policy and Spending - (Posted On Tuesday, August 24, 2021) Biden’s American Rescue Plan Follows Trend Toward Outpatient Setting, Increase in ASC Investment - (Posted On Thursday, May 20, 2021) Medi-Cal Rx: California to Transition Medi-Cal Pharmacy Benefits to Fee-For-Service - (Posted On Monday, January 11, 2021) CMS Announces New Geographic Direct Contracting Model: Letters of Interest Due by December 21, 2020 - (Posted On Tuesday, December 08, 2020) Eleventh Hour Rulemaking: HHS Eliminates Safe Harbor Protections for PBM Drug Rebates; and Creates Two New Safe Harbors for Point-of-Service Discounts and PBM Fixed-Fee Arrangements - (Posted On Wednesday, December 02, 2020) Texas v. California: SCOTUS Hears Oral Arguments About the Constitutionality of the ACA - (Posted On Tuesday, November 17, 2020) Primary Care First: CMS’s New Value-Based Approach to Primary Care - (Posted On Wednesday, November 11, 2020) The Next in the Series of Executive Orders Affecting the Pharmaceutical Industry - (Posted On Friday, September 18, 2020) President Trump’s Executive Order Mandating the Purchase of U.S. Drugs Evokes Criticism - (Posted On Wednesday, August 19, 2020) Pagination Page 1 Next page Next › Current Legal Analysis White House Policy Aims to Reshape Foreign Investment in the United States by: Eric R. Markus , Sevren R. Gourley Important Update – Treasury Will Not Enforce CTA Against U.S. Citizens, Domestic Reporting Companies and Their Beneficial Owners – New Rules To Follow (March 3, 2025 Edition) by: William E. Quick , Philip G. Feigen Exchanging the SEC: Previewing the Next Four Years by: Scott H. Kimpel Site-Neutral Medicare Proposals Currently on the Table: Considerations for Stakeholders by: Leigh Feldman , Devin Stone Staff Statement on Meme Coins Signals Significant Shift in SEC Position on Digital Assets by: Bert Stemmler , Daniel L. McAvoy What Whistleblowers Should Know About Reporting Market Manipulation to the CFTC and Qualifying for a CFTC Whistleblower Award by: Jason Zuckerman , Matthew Stock Another New Section 232 Investigation on Imports of Timber, Lumber and Derivative Products by: Deanna Tanner Okun , Lydia C. Pardini Congress Puts DOE & EPA Grants/Loans Under the Microscope by: Kristina M. Moore Upcoming Events Mar 5 2025 Workplace Wellness: Managing Stress & Anxiety for Peak Performance in Uncertain Times Mar 4 2025 DORA and the EU AI Act – Navigating New EU Rules Mar 4 2025 Navigating the Privacy Maze: Mastering Privacy and Data Security Issues in Mergers & Acquisitions Mar 5 2025 Defeating IRS Penalties – Key Insights & Strategies Print
